SEQOMBIX Trademark

Trademark Overview


On Friday, February 2, 2018, a trademark application was filed for SEQOMBIX with the United States Patent and Trademark Office. The USPTO has given the SEQOMBIX trademark a serial number of 87781740. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Celltrion, Inc.. The SEQOMBIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparation...
seqombix

General Information


Serial Number87781740
Word MarkSEQOMBIX
Filing DateFriday, February 2, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6197810
Registration DateTuesday, November 17, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelltrion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Party NameCelltrion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Party NameCelltrion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2018NEW APPLICATION ENTERED
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 15, 2018ASSIGNED TO EXAMINER
Wednesday, May 16, 2018NON-FINAL ACTION WRITTEN
Wednesday, May 16, 2018NON-FINAL ACTION E-MAILED
Wednesday, May 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 23, 2018ASSIGNED TO LIE
Monday, August 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 28, 2018SUSPENSION LETTER WRITTEN
Tuesday, August 28, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, August 28, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 2, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 24, 2019SUSPENSION LETTER WRITTEN
Thursday, January 24, 2019LETTER OF SUSPENSION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 24, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 8, 2019LETTER OF PROTEST EVIDENCE FORWARDED
Tuesday, October 8, 2019LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Friday, January 24, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Monday, November 17, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED